Revenue
2022
2023
2024
2025
Optibiotix Health plc (OPTI)
Price—Loading quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £1.2M | £870,000 | £644,000 | £457,000 |
| Research & development | £320,000 | £294,000 | £223,000 | £68,000 |
| Operating expenses | £3.7M | £2.6M | £2.0M | £10.8M |
| Operating income | −£3.1M | −£2.3M | −£1.7M | −£10.5M |
| Operating margin | −268.61% | −260.46% | −263.35% | −2,301.75% |
| EBITDA | −£2.9M | −£2.1M | −£1.5M | £2.7M |
| EBITDA margin | −251.03% | −236.44% | −231.52% | 583.15% |
| Net income | −£3.9M | −£1.8M | −£2.0M | £2.6M |
| Net profit margin | −333.62% | −207.47% | −316.61% | 566.08% |
| Basic EPSper basic share | -£0.04 | -£0.02 | -£0.02 | £0.03 |
| Diluted EPSper diluted share | -£0.04 | -£0.02 | -£0.02 | £0.03 |